Cargando…
Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid Receptor
Dezocine is an opioid that was used in clinical practice for acute pain management in the US (1986 to 2011) and is currently in use in China. It is not listed as a controlled substance in the US due to no reported cases of addiction. Dezocine is a partial agonist at the mu opioid receptor (MOR); how...
Autores principales: | Grothusen, John, Lin, Wenzhen, Xi, Jin, Zanni, Giulia, Barr, Gordon A., Liu, Renyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097853/ https://www.ncbi.nlm.nih.gov/pubmed/35572183 |
Ejemplares similares
-
In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
por: Zhang, Xiao, et al.
Publicado: (2020) -
The Anti-Nociception Effect of Dezocine in a Rat Neuropathic Pain Model
por: Wu, Fei-Xiang, et al.
Publicado: (2014) -
Usefulness for the combination of G protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance
por: Mori, Tomohisa, et al.
Publicado: (2017) -
Biased Opioid Ligands
por: Faouzi, Abdelfattah, et al.
Publicado: (2020) -
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
por: McCorvy, John D., et al.
Publicado: (2017)